MLYS logo

Mineralys Therapeutics (MLYS) return on equity

annual ROE:

-92.97%-63.16%(-211.88%)
December 31, 2024

Summary

  • As of today (June 17, 2025), MLYS annual return on equity is -92.97%, with the most recent change of -63.16% (-211.88%) on December 31, 2024.
  • During the last 3 years, MLYS annual ROE has fallen by -177.63% (-209.82%).
  • MLYS annual ROE is now -197.61% below its all-time high of 95.25%, reached on December 1, 2020.

Performance

MLYS ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLYSprofitability metrics

quarterly ROE:

-71.15%-3.18%(-4.68%)
March 31, 2025

Summary

  • As of today (June 17, 2025), MLYS quarterly return on equity is -71.15%, with the most recent change of -3.18% (-4.68%) on March 31, 2025.
  • Over the past year, MLYS quarterly ROE has dropped by -38.67% (-119.06%).
  • MLYS quarterly ROE is now -177.19% below its all-time high of 92.17%, reached on June 1, 2022.

Performance

MLYS quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLYSprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

MLYS ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-211.9%-119.1%
3 y3 years-209.8%-211.3%
5 y5 years-197.6%-330.3%

MLYS ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-209.8%at low-177.2%at low
5 y5-year-197.6%at low-177.2%at low
alltimeall time-197.6%at low-177.2%at low

MLYS ROE History

DateAnnualQuarterly
Mar 2025
-
-71.15%(+4.7%)
Dec 2024
-92.97%(+211.9%)
-67.97%(+21.5%)
Sep 2024
-
-55.92%(+31.2%)
Jun 2024
-
-42.61%(+31.2%)
Mar 2024
-
-32.48%(+22.7%)
Dec 2023
-29.81%
-26.48%(-7.3%)
Sep 2023
-
-28.55%(-14.5%)
Jun 2023
-
-33.39%(-36.0%)
DateAnnualQuarterly
Mar 2023
-
-52.21%(-183.8%)
Dec 2022
57.01%(-32.7%)
62.29%(-25.7%)
Sep 2022
-
83.84%(-9.0%)
Jun 2022
-
92.17%(+44.2%)
Mar 2022
-
63.91%(+106.8%)
Dec 2021
84.66%(-11.1%)
-
Dec 2021
-
30.90%
Dec 2020
95.25%
-

FAQ

  • What is Mineralys Therapeutics annual return on equity?
  • What is the all time high annual ROE for Mineralys Therapeutics?
  • What is Mineralys Therapeutics annual ROE year-on-year change?
  • What is Mineralys Therapeutics quarterly return on equity?
  • What is the all time high quarterly ROE for Mineralys Therapeutics?
  • What is Mineralys Therapeutics quarterly ROE year-on-year change?

What is Mineralys Therapeutics annual return on equity?

The current annual ROE of MLYS is -92.97%

What is the all time high annual ROE for Mineralys Therapeutics?

Mineralys Therapeutics all-time high annual return on equity is 95.25%

What is Mineralys Therapeutics annual ROE year-on-year change?

Over the past year, MLYS annual return on equity has changed by -63.16% (-211.88%)

What is Mineralys Therapeutics quarterly return on equity?

The current quarterly ROE of MLYS is -71.15%

What is the all time high quarterly ROE for Mineralys Therapeutics?

Mineralys Therapeutics all-time high quarterly return on equity is 92.17%

What is Mineralys Therapeutics quarterly ROE year-on-year change?

Over the past year, MLYS quarterly return on equity has changed by -38.67% (-119.06%)
On this page